Personality Disorders: Clinical Trials

528 trials for Personality Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

263 completed, 94 unknown, 79 recruiting, 26 not yet recruiting. 320 Not applicable, 51 Phase 2, 19 Phase 1, 18 Phase 3, 13 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable320Completed 148, Unknown 64, Recruiting 55, Not yet recruiting 17, Active not recruiting 16, Withdrawn 8, Enrolling by invitation 6, Terminated 5, Suspended 1
Phase 251Completed 30, Recruiting 8, Terminated 4, Unknown 4, Active not recruiting 2, Not yet recruiting 2, Suspended 1
Phase 119Completed 9, Not yet recruiting 3, Recruiting 2, Terminated 2, Unknown 2, Suspended 1
Phase 318Completed 15, Terminated 2, Withdrawn 1
Phase 413Completed 7, Unknown 3, Terminated 2, Withdrawn 1
Early Phase 14Completed 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow Personality Disorders: new trials by email Literature Review of Personality Disorders trials Research Report on Personality Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metacognitive Interpersonal Therapy for Male Intimate Partner Violence Perpetrators With Personality Disorders
Metacognitive Interpersonal Therapy for Male Domestic Offenders, Portuguese adaptation (MIT-MDO-PT) - Intimate Partner Violence, Personality Disorders
Not applicableNot yet recruitingHugo César Vicente72027-01-012026-09-29
Evaluating the Feasibility and Effects of PULS
PULS, TAU - Anti Social Behavior
Not applicableNot yet recruitingKarolinska Institutet2242027-01-012026-08-19
Efficacy of "DBT-LIVE", an Identity Skills Training Program, for Borderline Personality Disorder.
DBT LIVE, TAU - Treatment 1:Dialectical Behavior Therapy (DBT), Treatment as Usual
Not applicableNot yet recruitingUniversidad Europea de Valencia1122027-01-012026-07-06
ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder
Psilocybin, Psilocybin-Assisted Therapy With Dialectical Behavior Therapy - Borderline Personality Disorder, Borderline Personality Pathology
Phase 1Not yet recruitingUniversity of Minnesota182026-12-012026-09-22
Online Intervention To Improve Motivation
Online Motivation Enhancing Intervention - Schizophrenia Prodromal, SCHIZOPHRENIA 1 (Disorder)
Not applicableNot yet recruitingUniversity of Alabama at Birmingham602026-12-012026-10-13
Neurocomputational Dynamics of Cooperation
Social Learning Task Battery, Clinical Cohort, Social Learning Task Battery, Online Cohort - Social Cognition, Personality Disorder
Not applicableNot yet recruitingUniversity of Pittsburgh16122026-12-012026-10-06
tDCS and Symptom Provocation in Treatment-Resistant OCD
tDCS session, symptom provocation - Obsessive - Compulsive Disorder
Not applicableNot yet recruitingCentre Hospitalier Henri Laborit1782026-12-012026-10-21
Efficacy and Mechanism of Transcranial Temporal Interference Stimulation (tTIS) for Patients With Obsessive-Compulsive Disorders
Transcranial Temporal Interference Stimulation - Obsessive - Compulsive Disorder
Not applicableRecruitingBeijing HuiLongGuan Hospital802026-10-162026-09-04
Testing a Peer-led Trauma-focused Intervention for Significant Others of Those With BPD
Trauma Recovery Program (official title TBD) - Posttraumatic Stress Disorder, Family Members
Phase 1Not yet recruitingYork University602026-10-012026-07-29
Cohort Study of Obsessive-Compulsive Disorder
Obsessive - Compulsive Disorder
Not yet recruitingShanghai Mental Health Center5002026-09-152026-09-16
SONATA Dose Duration LIFU for OCD
ATTN201 - Low Intensity Focused Ultrasound - Obsessive - Compulsive Disorder
Phase 2RecruitingUniversity of Pennsylvania202026-09-152026-10-21
Psilocybin for Treatment of OCD-2
Low Dose Psilocybin, High Dose Psilocybin - Obsessive - Compulsive Disorder
Phase 1 / Phase 2Not yet recruitingFrancisco A Moreno202026-09-082026-05-12
Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder
IV Ketamine (0.5 mg/kg) Infusion - Two Doses Administered 24 Hours Apart for Severe Borderline Personality Disorder - Infusion of Ketamine in Severe Borderline Personality Disorder, Borderline Personality Disorder (BPD)
Phase 2Not yet recruitingUniversity Hospital, Toulouse382026-09-012026-05-12
Combining Transcranial Magnetic Stimulation With Emotion Regulation Skills Training in Borderline Personality Disorder
Transcranial Magnetic Stimulation (TMS), Emotion Regulation Skills Training - Borderline Personality Disorder (BPD)
Not applicableRecruitingMassachusetts General Hospital122026-09-012026-10-26
Clinical and Biological Correlates of Obsessive-Compulsive Disorder and Online Mindfulness-Based Cognitive Therapy
Mindfulness-based Cognitive Therapy for OCD - Obsessive - Compulsive Disorder
Not applicableRecruitingIRCCS Centro San Giovanni di Dio Fatebenefratelli422026-08-262026-09-25
Tracking Risk in Adolescents and Children for Early Identification of Common Mental Disorders
High Risk, Depression / Major Depressive Disorder
Not yet recruitingShanghai Mental Health Center2002026-07-252026-08-04
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Ketamine Hydrochloride, Midazolam Hydrochloride, Dialectical Behavioral Therapy (DBT) - Borderline Personality Disorder (BPD), Treatment-Resistant Major Depressive Disorder
Phase 2RecruitingJoshua Rosenblat1202026-07-162026-07-29
Effects of Transcranial Magnetic Stimulation on Social Cognition, Cognitive Processing, and Functional Brain Architecture
continuous theta burst stimulation (cTBS), Intermittent theta burst stimulation (iTBS), Sham - Psychopathy
Not applicableRecruitingUniversity of Colorado, Denver602026-07-132026-10-08
Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)
Exposure and Response Prevention (ERP), Habit Reversal Training (HbRT, Psychoeducation and Supportive Intervention - Obsessive - Compulsive Disorder, Tic Disorder, Chronic Motor or Vocal
Not applicableRecruitingUniversity College London Hospitals402026-07-082026-07-27
Exploring Equine-Assisted Psychotherapy as an Intervention for Those Who Have Received a Diagnosis of Emotionally Unstable Personality Disorder
Equine-Assisted Psychotherapy - Emotionally Unstable Personality Disorder, Borderline Type
Not applicableActive not recruitingCygnet Healthcare62026-06-172026-06-30

Showing 20 of 528. Sign in to see all of them.

Narrower conditions

Borderline Personality Disorder (275)  ·  Antisocial Personality Disorder (67)  ·  Psychotic Disorders (58)  ·  Depression (57)  ·  Schizotypal Personality Disorder (49)  ·  Schizophrenia (47)  ·  Anxiety Disorders (44)  ·  Compulsive Personality Disorder (39)  ·  Substance-Related Disorders (37)  ·  Mental Disorders (36)  ·  Self-Injurious Behavior (34)  ·  Bipolar Disorder (33)  ·  Stress Disorders, Post-Traumatic (32)  ·  Obsessive-Compulsive Disorder (23)

Broader conditions

Mental Disorders (492)  ·  Behavior (162)  ·  Behavioral Symptoms (119)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (78)  ·  Pathological Conditions, Signs and Symptoms (49)  ·  Mood Disorders (47)  ·  Chemically-Induced Disorders (43)  ·  Signs and Symptoms (42)  ·  Social Behavior (42)  ·  Trauma and Stressor Related Disorders (39)  ·  Stress Disorders, Traumatic (36)  ·  Neurodevelopmental Disorders (35)  ·  Bipolar and Related Disorders (32)  ·  Nervous System Diseases (25)

Interventions

Therapeutics (34)  ·  Dialectical Behavior Therapy (22)  ·  Cognitive Behavioral Therapy (11)  ·  Transcranial Magnetic Stimulation (11)  ·  Transcranial Direct Current Stimulation (9)  ·  Mentalization-Based Therapy (8)  ·  Exercise (5)  ·  Schema Therapy (5)  ·  Acetylcysteine (4)  ·  Eye Movement Desensitization Reprocessing (4)  ·  Magnetic Resonance Imaging (4)  ·  Palliative Care (4)  ·  Risperidone (4)  ·  Surveys and Questionnaires (4)  ·  Cognitive Remediation (3)

Sponsors

University of Minnesota (9)  ·  Icahn School of Medicine at Mount Sinai (8)  ·  University Hospital, Montpellier (8)  ·  Centre for Addiction and Mental Health (7)  ·  University Hospital, Toulouse (7)  ·  Yale University (7)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (6)  ·  IRCCS Centro San Giovanni di Dio Fatebenefratelli (6)  ·  Karolinska Institutet (6)  ·  Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (6)  ·  Region Skane (6)  ·  Oslo University Hospital (5)  ·  Shalvata Mental Health Center (5)  ·  Shanghai Mental Health Center (5)  ·  University Hospital, Strasbourg, France (5)

Countries

United States (147)  ·  Germany (48)  ·  France (47)  ·  Canada (31)  ·  Spain (27)  ·  Denmark (25)  ·  United Kingdom (24)  ·  Netherlands (22)  ·  Italy (19)  ·  Norway (18)  ·  Sweden (16)  ·  Switzerland (13)  ·  China (10)  ·  Israel (7)  ·  Belgium (6)

Top investigators

Amy Longcore (3)  ·  Marianne Goodman, MD (3)  ·  Adrian Raine (2)  ·  Adrian Raine, DPhil (2)  ·  Alexandra Philipsen, Prof. (2)  ·  Andrada D Neacsiu, PhD (2)  ·  Are Holen, PhD MD (2)  ·  Harold Koenigsberg, MD (2)  ·  Harold W Koenigsberg, MD (2)  ·  Jon E Grant, MD, JD, MPH (2)  ·  Kathleen Thomaes, MD/PhD (2)  ·  Larry J Siever, MD (2)  ·  Lars Mehlum, MD PhD (2)

Results publications

PMID 32368793, PMID 36375174, PMID 33884617, PMID 32880104, PMID 16013747, PMID 17257517, PMID 28861273, PMID 36803673, PMID 21095016, PMID 22967772, PMID 33947471, PMID 38527104, PMID 39558901, PMID 40014392, PMID 10591283, PMID 10591284, PMID 10637676, PMID 10637677, PMID 10668619, PMID 10720283, PMID 11104313, PMID 11104315, PMID 11104317, PMID 11211363, PMID 11211364, PMID 11211365, PMID 11211366, PMID 11211367, PMID 11294072, PMID 11781034, PMID 12014781, PMID 12108764, PMID 12271808, PMID 12549710, PMID 12795577, PMID 12823075, PMID 12880507, PMID 1403624, PMID 14979218, PMID 14998110, PMID 15060225, PMID 15498733, PMID 15677282, PMID 1580810, PMID 15863743, PMID 15931222, PMID 16051730, PMID 16055815, PMID 16055817, PMID 16101975

NIH funding

2019 (2), 2025 (2), R01MH061017 (2), 2002 (1), 2017 (1), K01MH131872 (1), K05DA015226 (1), K05MH000797 (1), K23DA027720 (1), K23MH071641 (1), K23MH106648 (1), K23MH126211 (1), K23MH139637 (1), KL2RR025754-04 (1), P30DA023026 (1)